These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2363170)

  • 1. [Experiences from two HIV prevention projects among drug abusers in Oslo. Is methadone maintenance treatment useful?].
    Skogstad M
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1978-80. PubMed ID: 2363170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methadone maintenance of HIV-infected drug addicts with immune deficiency].
    Waal H; Knutsen T; Welle-Strand G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3083-6. PubMed ID: 1658974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization.
    Turner BJ; Laine C; Yang CP; Hauck WW
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S457-63. PubMed ID: 14648464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of HIV infection in the methadone program. A study of a drop-in clinic in Zurich].
    Huber-Stemich F; Haas H
    Schweiz Rundsch Med Prax; 1990 Sep; 79(36):1017-21. PubMed ID: 2218224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV testing and risk-prone behavior among drug abusers in Oslo].
    Welle-Strand GK
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1551-4. PubMed ID: 2339408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse and HIV infection.
    Francis H
    Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of methadone treatment on registered convictions and arrests in HIV-positive and HIV-negative men and women with one or more treatment periods.
    Stenbacka M; Leifman A; Romelsjö A
    Drug Alcohol Rev; 2003 Mar; 22(1):27-34. PubMed ID: 12745356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edinburgh's community drug problem service--a pilot evaluation of methadone substitution.
    Chalmers JW
    Health Bull (Edinb); 1990 Mar; 48(2):62-72. PubMed ID: 2332336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of HIV infection among parenteral drug abusers.
    Cushman P; Escobar M
    J Subst Abuse; 1989; 1(4):461-5. PubMed ID: 2485291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?
    Anthony IC; Ramage SN; Carnie FW; Simmonds P; Bell JE
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):325-38. PubMed ID: 15885069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of primary care services by drug users attending a HIV prevention unit.
    Bury G; O'Kelly F; Pomeroy L
    Ir Med J; 1993 Mar; 86(2):53-5. PubMed ID: 8473136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug abuse in Nepal: a rapid assessment study.
    Chatterjee A; Uprety L; Chapagain M; Kafle K
    Bull Narc; 1996; 48(1-2):11-33. PubMed ID: 9839033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skills-training groups to reduce HIV transmission and drug use among methadone patients.
    Schilling RF; el-Bassel N; Hadden B; Gilbert L
    Soc Work; 1995 Jan; 40(1):91-101. PubMed ID: 7863377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug injecting and HIV infection among the population of drug abusers in Asia.
    Poshyachinda V
    Bull Narc; 1993; 45(1):77-90. PubMed ID: 8305908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.